Anebulo Pharmaceuticals, Inc.
ANEB- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815974
No open-market purchases or sales by Anebulo Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of ANEB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Anebulo Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| English Aron R. | 13D/A | 51.10%21.9M shares | 0.00 ppfrom 51.10% | Dec 26, 20242 filings | Feb 27, 2025 | SEC |
| Nantahala Capital Management, LLC | 13G/A | 8.53%3.55M shares | −0.10 ppfrom 8.63% | Feb 14, 20252 filings | Feb 13, 2026 | SEC |
| Mangrove Partners | 13G | 6.15%2.53M shares | New | Mar 17, 20251 filing | Mar 17, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Anebulo Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20265:00 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 8.53%3.55M shares | −0.10 ppfrom 8.63% | Dec 31, 2025 | SEC |
| Mar 17, 20254:51 PM ET | Mangrove Partnersand 1 other | 13G | 6.15%2.53M shares | New | Dec 31, 2024 | SEC |
| Feb 27, 20257:41 AM ET | English Aron R.and 2 others | 13D/A | 51.10%21.9M shares | 0.00 ppfrom 51.10% | Feb 24, 2025 | SEC |
| Feb 14, 20254:32 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 8.63%3.55M shares | New | Dec 31, 2024 | SEC |
| Dec 26, 20249:42 PM ET | English Aron R.and 2 others | 13D/A | 51.10%21.9M shares | – | Dec 23, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Anebulo Pharmaceuticals, Inc. shares.
No Form 144 notices for Anebulo Pharmaceuticals, Inc. are on file.